A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 11, 2013, Pages

  Worcester, Elaine M ^a   Evan, Andrew P ^b   Coe, Fredric L ^a   Lingeman, James E ^b   Krambeck, Amy ^c   Sommers, Andre ^d   Phillips, Carrie L ^e   Milliner, Dawn ^f  

^a UNIVERSITY OF CHICAGO   (United States)

^b INDIANA UNIVERSITY   (United States)

^c DEPARTMENT OF UROLOGY   (United States)

^d MIAMI UNIVERSITY   (United States)

^e INDIANA UNIVERSITY HEALTH   (United States)

^f MAYO CLINIC   (United States)

Author keywords

Calcium oxalate; Primary hyperoxaluria; Proximal tubule; Renal histopathology

Indexed keywords

CALCIUM OXALATE; CREATININE; HYALURONIC ACID;

ACID SECRETION; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CRYSTALLIZATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; INFLAMMATION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MALE; OXALOSIS 1; PRESCHOOL CHILD; PRIORITY JOURNAL; SCAR FORMATION;

EID: 84888782176     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00382.2013     Document Type: Article

References (61)

1. Alper SL, Sharma AK. The SLC26 gene family of anion transporters and channels. Mol Aspects Med 34: 494-515, 2013.
2. Asselman M, Verhulst A, van Bullegooijen ES, Bangma CH, Verkoelen CF, De Broe ME. Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells. Kidney Int 68: 71-83, 2005.
3. Barbato A, Cappuccio FP, Folkerd EJ, Strazzullo P, Sampson B, Cook DG, Alberti KGMM. Metabolic syndrome and renal sodium handling in three ethnic groups living in England. Diabetologia 47: 40-46, 2004.
4. Bergsland KJ, Zisman AL, Asplin JR, Worcester EM, Coe FL. Evidence of net tubule secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol 300: F311-F318, 2011.
5. Bochud M, Staessen JA, Maillard M, Mazeko MJ, Kuznetsova T, Woodiwiss A, Richart T, Norton G, Thijs L, Elston R, Burnier M. Ethnic differences in proximal and distal tubular sodium reabsorption are heritable in black and white populations. J Hypertens 27: 606-612, 2009.
6. Boer WH, Koomans HA, Dorhout Mees EJ. Lithium clearance in healthy humans suggesting lithium reabsorption beyond the proximal tubule. Kidney Int 28: S39-S44, 1990.
7. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155: 839-843, 1996.
8. Byer K, Khan SR. Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol 173: 640, 2005.
9. Cryer PE, Garber AJ, Hoffsten P, Lucas B, Wise L. Renal failure after small intestinal bypass for obesity. Arch Intern Med 135: 1610-1612, 1975.
10. Dhaun N, Ferro CJ, Davenport AP, Haynes WG, Goddard J, Webb DJ. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease. Nephrol Dial Transplant 22: 3228-3234, 2007.
11. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM. Renal intraluminal crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec 291: 325-334, 2008.
12. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Worchester EM. Renal crystal deposits and histopathology in patients with cystine stones. J Urol 175: 498, 2006.
13. Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Worcester EM. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int 76: 1081-1088, 2009.
14. Evan AE, Lingeman JE, Coe FL, Miller NL, Bledsoe SB, Sommer AJ, Williams JC, Shao Y, Worcester EM. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 74: 223-229, 2008.
15. Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester E. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71: 795-801, 2007.
16. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607-616, 2003.
17. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67: 576-591, 2005.
18. Evan AP, Lingeman JE, Worcester EM, Bledsoe SB, Sommer AJ, Williams JC Jr, Krambeck AE, Philips CL, Coe FL. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 78: 310-317, 2010.
19. Finlayson B. Calcium stone: some physical and clinical aspects. In: Calcium Metabolism in Renal Failure and Nephrolithiasis, edited by David DS. New York: John Wiley & Sons, 1977, p. 337-382.
20. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardic function. Kidney Int 51: 1196-1204, 1997.
21. Hackett RL, Shevock PN. Crystal-cell interaction: its role in the development of stone disease. In: Calcium oxalate in Biological Systems, edited by Khan, S. Boca Raton, FL: CRC, 1995.
22. Hayslett JP. Functional adaptation to reduction in renal mass. Physiol Rev 59: 137-163, 1979.
23. Hennigar RA, Schulte BA, Spicer SS. Heterogeneous distribution of glycoconjugates in human kidney tubules. Anat Rec 211: 376-390, 1985.
24. Hoppe B, Kemper MJ, Bokenkamp A, Portale AA, Cohn RA, Langman CB. Plasma calcium-oxalate supersaturation in children with primary hyperoxaluria and end stage renal disease. Kidney Int 56: 268-274, 1999.
25. Jamison RL, Kriz W. Thick ascending limb. In: Urinary Concentrating Mechanism: Structure and Function. New York: Oxford Univ. Press, p.173-188, 1985.
26. Kaissling B, Kritz W. Structural analysis of the rabbit kidney. Adv Anat Embryol Cell Biol 56: 1-123, 1979.
27. Khan SR. Crystal-induced inflammation of the kidneys: results from human studies animal models and tissue-culture studies. Clin Exp Nephrol 8: 75-88, 2004.
28. Khan SR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: Evidence from clinical and experimental investigations. J Urol 189: 803-811, 2013.
29. Khan SR, Glenton PA, Byer KJ. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxyl-L-proline. Kidney Int 70: 914-923, 2006.
30. Khan SR, Hackett RL. Calcium oxalate urolithiasis in rat: is it a model for human disease. Scanning Microsc 2: 759-774, 11985.
31. Khan SR, Hackett RL. Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 5: 707-712, 1991.
32. Kim SC, Coe F, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE. Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol 173: 117-119, 2005.
33. Knauf F, Asplin JR, Granja I, Schmidt IM, Moeckel GW, David RJ, Flavell RA, Aronson PS. NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy. Kidney Int 2013 Jun 5 [Epub ahead of print].
34. Koomans HA, Boer WH, Dorhout Mees EJ. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 38: 2-12, 1989.
35. Kujala M, Tienari J, Lohi H, Elomaa O, Sariola H, Lehtnen E, Kere J. SLC26A6 and SLC26A7 anion exchangers have a distinct distribution in human kidney. Nephron Exp Nephrol 101: e50-e58, 2005.
36. Ladwig PM, Liedtke RR, Larson T, Lieske JC. Sensitive spectrophotometric sssay for plasma oxalate. Clin Chem 51: 2377-2380, 2005.
37. Lieski JC, Deganello S. Nucleation, adhesion and internalization of calcium-containing urinary crystals by renal cells. J Am Soc Nephrol 14: S422-429, 1999.
38. Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorni A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Andres HJ. Calcium oxalte crystals induce renal inflammation by NLRP3-mediated IL-1 secretion. J Clin Invest 123: 236-346, 2013.
39. Murty MLN, Garg I, Date A, Jacob CK, Kirubakaran MG, Shastry JC. Renal histology for the diagnosis of primary hyperoxaluria in patients with end-stage renal disease. Nephron 53: 81-82, 1989.
40. Parks JH, Coe FL, Evan AP, Worcester EM. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperpararthyroidism. BJU Int 103: 670-678, 2008.
41. Rouse D, Ng RC, Suki WN. Calcium transport in the pars recta and thin descending limb of Henle of the rabbit perfused in vitro. J Clin Invest 65: 37-42, 1980.
42. Salmond R, Seney FD. Reset tubuloglomerular feedback permits and sustains glomerular hyperfunction after extensive renal ablation. Am J Physiol Renal Fluid Electrolyte Physiol 260: F395-F401, 1991.
43. Scheid CR, Koul HK, Kennington L, Hill WA, Luber-Narod J, Jonassen J, Honeyman T, Menon M. Oxalate-induced damage to renal tubular cells. Scanning Microsc 9: 1097-1105, 1995.
44. Schwartz-Sorensen S, Amdisen A, Pedersen EBA. Abnormal proximal tubular sodium handling in normotensive patients with chronic glomerulonephritis and normal glomerular filtration rate. Scand J Clin Lab Invest 47: 785-791, 1987.
45. Shidham V, Chivukula M, Basir Z, Shidham G. Evaluation of crystals in formalin-fixed, paraffin-embedded tissue sections for differential diagnosis of pseudogout, gout and tumoral calcinosis. Mod Pathol 14: 806-810, 2001.
46. Sindic A, Chang MH, Mount DB, Romero MF. Renal physiology of SLC26 anion exchangers. Curr Opin Nephrol Hypertens 16: 484-490, 2007.
47. Sorensen SS, Amdisen A, Pedersen EB. Abnormal proximal tubular sodium handling in normotensive patients with chronic glomerulonephritis and normal glomerular filtration rate. Scand J Clin Invest 47: 785-791, 1987.
48. Stenvinkel P, Ottosson-Seeberger A, Alvestrand A. Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia. J Am Soc Nephrol 5: 1751-1760, 1995.
49. Stokke ES, Ostensen J, Hartmann A, Kiii K. Loop diuretics reduce lithium reabsorption without affecting bicarbonate and phosphate reabsorption. Acta Physiol Scand 140: 111-118, 1990.
50. TietzeIN, Pedersen EB. Renal haemodynamic changes, renal tubular function, sodium, and water homeostatic hormones in patients with chronic glomerulonephritis and in healthy humans after intravenous infusion of amino acids. Nephrol Dial Transplant 9: 499-504, 1994.
51. Truong LD, Phung VT, Yoshikawa Y, Mattioli CA. Glycoconjugates in normal human kidney. A histochemical study using 13 biotinylated lectins. Histochemistry 90: 51-60, 1988.
52. Umekawa T, Byer K, Uemura H. Diphenyleneiodium (DPI) reduces oxalate ion-and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20: 870-878, 2005.
53. Unwin RJ, Walter SJ, Shirley DG. Lithium reabsorption in perfused loops of Henle: effects of perfusion rate and bumetanide. Am J Physiol Renal Fluid Electrolyte Physiol 266: F806-F812, 1994.
54. Verhulst A, Asselman M, Naeyer SD, Vervaet BA, Mengel M, Gwinner W, D'Haese PC, Verkoelen CF, De Broe ME. Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int 68: 1643-1647, 2005.
55. Vervaet BA, D'Haese PC, De Broe ME, Verhulst A. Crystalluric and tubular epithelial parameters during the onset of intratubular nephrocalcinosis: illustration if the "fixed particle" theory in vivo. Nephrol Dial Transplant 24: 3659-3668, 2009.
56. Vervaet BA, Verhuls TA, D'Haese PC, De Broe ME. Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol Dial Transplant 24: 2030-2035, 2009.
57. Walter SJ, Shirley DG, Unwin RJ. Effect of vasopressin on renal lithium reabsorption: a micropuncture and microperfusion study. Am J Physiol Renal Fluid Electrolyte Physiol 271: F223-F229, 1996.
58. Wilson DM, Liedtke RR. Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures. Clin Chem 37: 1229-1235, 1991.
59. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol 295: F1286-F1294, 2008.
60. Worcester Nakagawa Y EM, Bushinsky DA, Coe FL. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 77: 1888-1896, 1986.
61. Zamlauski-Tucker MJ, Van Liew JB, Goldinger J, Noble B. Persistent proximal tubule dysfunction late in Heymann nephritis. Kidney Int 37: 1536-1542, 1990.